<DOC>
	<DOCNO>NCT00442923</DOCNO>
	<brief_summary>The purpose research study determine whether Carvedilol , FDA approve beta blocker , administer 8-week period veteran currently undergo treatment methamphetamine dependence ( 1 ) improve ability stay treatment longer , ( 2 ) ease aversive symptom accompany stimulant withdrawal , ( 3 ) increase time remain abstinent methamphetamine .</brief_summary>
	<brief_title>`` The Evaluation Stimulant Withdrawal ''</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Must enter treatment outpatient Clinical Addiction Rehabilitation Section ( CARS ) US Portland Veterans Affairs Medical Center Must meet clinical definition methamphetamine dependence Selfreported methamphetamine use within 10 day enter study Must able understand sign consent form Dependent drug except nicotine , caffeine , marijuana alcohol Pregnant nursing mother Psychosis Dementia Any serious medical condition could aggravate study protocol ( Allergic reaction , Hypotension , Asthma , Bronchospastic condition , Angina , Bronchitis , Emphysema , Bradycardia , Heart blood vessel disease , Diabetes mellitus , Low blood sugar , Kidney disease , Liver disease Overactive thyroid ) History withdrawal seizures delirium tremor Use MAO inhibitor within last two week Considerable hepatocellular injury , include cirrhosis liver liver function test level higher 2 time normal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Methamphetamine</keyword>
	<keyword>Coreg</keyword>
	<keyword>Withdrawal</keyword>
	<keyword>anxiety</keyword>
	<keyword>Substance Addiction</keyword>
</DOC>